IPSC vs MTD · rev $6.6M vs P/E 27, rev $3.87B
Century Therapeutics Inc (IPSC) versus Mettler-Toledo International Inc (MTD) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported MTD revenue for 2024-12-31 was $3.87B. Net income was $863.1M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
IPSC currently screens at market cap $47.8M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Not investment advice. Open the IPSC and MTD stock pages for the full models.
Not investment advice.